Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-11

Clinical Trial Update: The Impact of Riboflavin on Sports-related Concussion [Phase 2]

View source ↗

Summary

A Phase 2 trial from the University of Virginia is evaluating riboflavin for sports-related concussion, with results not yet reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Riboflavin (riboflavin)

Snippet

Sponsor: University of Virginia | Conditions: Sports-related Concussion | Phase 2 | Status: UNKNOWN